MedPath

Nitrostat

Nitrostat (Nitroglycerin Sublingual Tablets, USP)

Approved
Approval ID

dcb552c1-310a-48af-81ad-a74530531dee

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 16, 2012

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

nitroglycerin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-450
Application NumberNDA021134
Product Classification
M
Marketing Category
C73594
G
Generic Name
nitroglycerin
Product Specifications
Route of AdministrationSUBLINGUAL
Effective DateApril 30, 2010
FDA Product Classification

INGREDIENTS (5)

nitroglycerinActive
Quantity: 0.4 mg in 1 1
Code: G59M7S0WS3
Classification: ACTIB
lactose monohydrateInactive
Code: EWQ57Q8I5X
Classification: IACT
calcium stearateInactive
Code: 776XM7047L
Classification: IACT
glyceryl monostearateInactive
Code: 230OU9XXE4
Classification: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nitrostat - FDA Drug Approval Details